568 related articles for article (PubMed ID: 24530145)
1. Cost-effectiveness of a potential group B streptococcal vaccine program for pregnant women in South Africa.
Kim SY; Russell LB; Park J; Verani JR; Madhi SA; Cutland CL; Schrag SJ; Sinha A
Vaccine; 2014 Apr; 32(17):1954-63. PubMed ID: 24530145
[TBL] [Abstract][Full Text] [Related]
2. Prevention of group B streptococcal disease in the first 3 months of life: would routine maternal immunization during pregnancy be cost-effective?
Oster G; Edelsberg J; Hennegan K; Lewin C; Narasimhan V; Slobod K; Edwards MS; Baker CJ
Vaccine; 2014 Aug; 32(37):4778-85. PubMed ID: 24992717
[TBL] [Abstract][Full Text] [Related]
3. Cost-effectiveness of a potential group B streptococcal vaccine for pregnant women in the United States.
Kim SY; Nguyen C; Russell LB; Tomczyk S; Abdul-Hakeem F; Schrag SJ; Verani JR; Sinha A
Vaccine; 2017 Oct; 35(45):6238-6247. PubMed ID: 28951085
[TBL] [Abstract][Full Text] [Related]
4. Intrapartum antibiotic prophylaxis for the prevention of perinatal group B streptococcal disease: experience in the United States and implications for a potential group B streptococcal vaccine.
Schrag SJ; Verani JR
Vaccine; 2013 Aug; 31 Suppl 4():D20-6. PubMed ID: 23219695
[TBL] [Abstract][Full Text] [Related]
5. Considerations for a phase-III trial to evaluate a group B Streptococcus polysaccharide-protein conjugate vaccine in pregnant women for the prevention of early- and late-onset invasive disease in young-infants.
Madhi SA; Dangor Z; Heath PT; Schrag S; Izu A; Sobanjo-Ter Meulen A; Dull PM
Vaccine; 2013 Aug; 31 Suppl 4():D52-7. PubMed ID: 23973347
[TBL] [Abstract][Full Text] [Related]
6. Cost-effectiveness analysis of maternal immunisation against group B Streptococcus (GBS) disease: A modelling study.
Giorgakoudi K; O'Sullivan C; Heath PT; Ladhani S; Lamagni T; Ramsay M; Al-Janabi H; Trotter C
Vaccine; 2018 Nov; 36(46):7033-7042. PubMed ID: 30293765
[TBL] [Abstract][Full Text] [Related]
7. Cost-effectiveness of maternal GBS immunization in low-income sub-Saharan Africa.
Russell LB; Kim SY; Cosgriff B; Pentakota SR; Schrag SJ; Sobanjo-Ter Meulen A; Verani JR; Sinha A
Vaccine; 2017 Dec; 35(49 Pt B):6905-6914. PubMed ID: 29129451
[TBL] [Abstract][Full Text] [Related]
8. Preventing neonatal group B streptococcal infection. Intrapartum antibiotic prophylaxis in some high-risk situations.
Prescrire Int; 2011 Mar; 20(114):72-7. PubMed ID: 21648230
[TBL] [Abstract][Full Text] [Related]
9. Early-onset group B streptococcal disease in the era of maternal screening.
Puopolo KM; Madoff LC; Eichenwald EC
Pediatrics; 2005 May; 115(5):1240-6. PubMed ID: 15867030
[TBL] [Abstract][Full Text] [Related]
10. Cost-effectiveness of maternal immunization against neonatal invasive Group B Streptococcus in the Netherlands.
Hahn BA; de Gier B; van Kassel MN; Bijlsma MW; van Leeuwen E; Wouters MGAJ; van der Ende A; van de Beek D; Wallinga J; Hahné SJM; Jan van Hoek A
Vaccine; 2021 May; 39(21):2876-2885. PubMed ID: 33895018
[TBL] [Abstract][Full Text] [Related]
11. Efficacy of a strategy to prevent neonatal early-onset group B streptococcal (GBS) sepsis.
Renner RM; Renner A; Schmid S; Hoesli I; Nars P; Holzgreve W; Surbek DV
J Perinat Med; 2006; 34(1):32-8. PubMed ID: 16489884
[TBL] [Abstract][Full Text] [Related]
12. Prevention of early-onset Group B Streptococcal disease - the Northern Ireland experience.
Eastwood KA; Craig S; Sidhu H; Boyle M; Gannon C; Ong G; Lupari M; Craven A; Magowan S; Ashe RG
BJOG; 2015 Feb; 122(3):361-7. PubMed ID: 24861487
[TBL] [Abstract][Full Text] [Related]
13. Cost-effectiveness of different treatment strategies with intrapartum antibiotic prophylaxis to prevent early-onset group B streptococcal disease.
Akker-van Marle ME; Rijnders ME; Dommelen P; Fekkes M; Wouwe JP; Amelink-Verburg MP; Verkerk PH
BJOG; 2005 Jun; 112(6):820-6. PubMed ID: 15924544
[TBL] [Abstract][Full Text] [Related]
14. Comparison of prevention strategies for neonatal group B streptococcal infection. A population-based economic analysis.
Mohle-Boetani JC; Schuchat A; Plikaytis BD; Smith JD; Broome CV
JAMA; 1993 Sep 22-29; 270(12):1442-8. PubMed ID: 8371444
[TBL] [Abstract][Full Text] [Related]
15. The Italian arm of the PREPARE study: an international project to evaluate and license a maternal vaccine against group B streptococcus.
Berardi A; Cassetti T; Creti R; Vocale C; Ambretti S; Sarti M; Facchinetti F; Cose S; ; Heath P; Le Doare K
Ital J Pediatr; 2020 Oct; 46(1):160. PubMed ID: 33115542
[TBL] [Abstract][Full Text] [Related]
16. Prevention of perinatal group B streptococcal disease--revised guidelines from CDC, 2010.
Verani JR; McGee L; Schrag SJ;
MMWR Recomm Rep; 2010 Nov; 59(RR-10):1-36. PubMed ID: 21088663
[TBL] [Abstract][Full Text] [Related]
17. The projected health benefits of maternal group B streptococcal vaccination in the era of chemoprophylaxis.
Sinha A; Lieu TA; Paoletti LC; Weinstein MC; Platt R
Vaccine; 2005 May; 23(24):3187-95. PubMed ID: 15837219
[TBL] [Abstract][Full Text] [Related]
18. 20 million pregnant women with group B streptococcus carriage: consequences, challenges, and opportunities for prevention.
Paul P; Gonçalves BP; Le Doare K; Lawn JE
Curr Opin Pediatr; 2023 Apr; 35(2):223-230. PubMed ID: 36749143
[TBL] [Abstract][Full Text] [Related]
19. Preventing the broad spectrum of perinatal morbidity and mortality through group B streptococcal vaccination.
Edwards MS; Gonik B
Vaccine; 2013 Aug; 31 Suppl 4():D66-71. PubMed ID: 23200934
[TBL] [Abstract][Full Text] [Related]
20. Vaccination for Group B Streptococcus during pregnancy: attitudes and concerns of women and health care providers.
Patten S; Vollman AR; Manning SD; Mucenski M; Vidakovich J; Davies HD
Soc Sci Med; 2006 Jul; 63(2):347-58. PubMed ID: 16545514
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
